Nuveen Asset Management, LLC Cidara Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.87 - $2.7 $369,356 - $533,295	-197,517 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.06 - $3.01 $128,251 - $187,396	62,258 Added 46.03%	197,517 $526,000
Q4 2020 Feb 16, 2021	BUY	$1.99 - $3.25 $2,612 - $4,267	1,313 Added 0.98%	135,259 $270,000
Q3 2020 Nov 16, 2020	SELL	$2.85 - $4.1 $82,507 - $118,694	-28,950 Reduced 17.77%	133,946 $382,000
Q2 2020 Aug 14, 2020	BUY	$2.39 - $4.0 $389,321 - $651,584	162,896 New	162,896 $602,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.42B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.